Nanotechnology products from Liquidia Technologies will first find their way to most Americans in medicine. The company’s proprietary method of making nanoparticles enables targeted drug delivery of medicines and vaccines. While Liquidia CEO Neal Fowler believes the technology will transform drug delivery around the world, he says his Research Triangle Park, North Carolina company sees […]
North Carolina nanotechnology company Liquidia Technologies is partnering with nonprofit organization PATH to develop a new pneumonia vaccine that could be deployed globally. Research Triangle Park-based Liquidia is working with PATH to conduct preclinical studies on a “next-generation” pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce. Financial terms […]
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
North Carolina’s nanotechnology presence doesn’t immediately come to mind when thinking of the country’s biggest nanotech hubs, a skeptic of the industry recently told me. In a way, he’s right, at least right now. Nanotechnology has found a comfortable home in manufacturing and industrial applications that were developed primarily at tech hubs in other parts […]